Researcher
Esther WOLFS
- Keywords:Biomedical sciences (incl. biochemistry)
- Disciplines:Oral medicine and pathology, Nuclear imaging, Medical imaging and therapy not elsewhere classified, Histology, Neurological and neuromuscular diseases, Cancer therapy, Cell therapy, Tissue engineering
Affiliations
- Cardio & organ systems (Department)
Member
From1 Jan 2020 → Today - Cardio & organ systems (Research group)
Member
From1 Jan 2020 → Today - Biomedical Research Institute (Research institute)
Member
From16 Jun 2014 → Today - Faculty of Medicine and Life Sciences (Faculty)
Member
From16 Jun 2014 → Today - Morphology (Department)
Member
From16 Jun 2014 → 31 Dec 2019 - Morphology (Research group)
Member
From16 Jun 2014 → 31 Dec 2019
Projects
1 - 10 of 19
- Plasma-treated hydrogels as a new selective therapy for head and neck cancerFrom1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- IGF-2 and Des(1-6)IGF-2 as new tools to boost neurogenesis after ischemic stroke.From1 Nov 2023 → TodayFunding: FWO fellowships
- Disturbances in Phospholipid Turnover in Charcot-Marie-Tooth disease Type 1AFrom1 Nov 2023 → TodayFunding: FWO fellowships
- Creation of a humanized mouse model for Charcot Marie Tooth disease type 1AFrom1 Oct 2023 → TodayFunding: BOF - postdoctoral mandates
- Creation of a humanized mouse model for demyelinating peripheral neuropathies as a platform for therapeutic testing.From1 Jan 2023 → TodayFunding: BOF - iBOF
- Development of a new CMT1A research toolbox: an alternative human stem cell-based strategyFrom1 Jan 2022 → TodayFunding: Foreign foundations, funds with scientific view
- The molecular hug between the ER and mitochondria in Charcot- Marie-Tooth disease type 1AFrom1 Nov 2021 → 31 Oct 2023Funding: FWO fellowships
- Protein misfolding in Charcot-Marie-Tooth disease type 1A: opening the gates for cathepsin B and peripheral nerve demyelination.From1 Nov 2021 → 31 Oct 2023Funding: FWO fellowships
- Future proof pathology for predictive medicine and disease prognosis based on tumor heterogeneity.From1 Jan 2021 → TodayFunding: BOF - projects
- NEED - Bioresponsive nanocarriers as a therapy for cancer and wound healing.From1 Jan 2021 → TodayFunding: BOF - projects
Publications
1 - 10 of 47
- Pyridoxamine Attenuates Doxorubicin-Induced Cardiomyopathy without Affecting Its Antitumor Effect on Rat Mammary Tumor Cells(2024)
Authors: Sibren HAESEN, Eline VERGHOTE, Ellen HEEREN, Esther WOLFS, Dorien DELUYKER, Virginie BITO
- The sphingosine-1-phosphate receptor 1 modulator ponesimod repairs cuprizone-induced demyelination and induces oligodendrocyte differentiation(2024)
Authors: Emily WILLEMS, Melissa SCHEPERS, Elisabeth PICCART, Esther WOLFS, Niels HELLINGS, Maria Ait-Tihyaty, Tim VANMIERLO
- The Effect of Leukocyte- and Platelet-Rich Fibrin on Central and Peripheral Nervous System Neurons-Implications for Biomaterial Applicability(2023)
Authors: Ivo LAMBRICHTS, Esther WOLFS, Annelies BRONCKAERS, Pascal GERVOIS, Tim VANGANSEWINKEL
- Extracellular vesicle-associated cholesterol supports the regenerative functions of macrophages in the brain(2023)
Authors: Sam VANHERLE, Jeroen GUNS, Melanie LOIX, Fleur MINGNEAU, Tess DIERCKX, Flore WOUTERS, Koen KUIPERS, Tim VANGANSEWINKEL, Esther WOLFS, Paula PINCELA LINS, et al.
- Pyridoxamine Limits Mitochondria-Dependent Ferroptosis in a Rat Model of Doxorubicin-Induced Cardiotoxicity(2023)
Authors: Sibren HAESEN, Eline VERGHOTE, Anouk Delaet, Esther WOLFS, Dorien DELUYKER, Virginie BITO
Pages: A15199 - A15199 - Selective PDE4 subtype inhibition provides new opportunities to intervene in neuroinflammatory versus myelin damaging hallmarks of multiple sclerosis(2023)
Authors: Melissa SCHEPERS, Dean PAES, Assia TIANE, Ben ROMBAUT, Elisabeth PICCART, Lieve VAN VEGGEL, Pascal GERVOIS, Chiara Brullo, Olga Bruno, Ernesto Fedele, et al.
Pages: 1 - 22 - Carnosine synthase deficiency aggravates neuroinflammation in multiple sclerosis(2023)
Authors: Jan SPAAS, Thibaux Van der Stede, Sarah de Jager, Annet VAN DE WATERWEG BERENDS, Assia TIANE, Hans Baelde, Shahid P. Baba, Matthias Eckhardt, Esther WOLFS, Tim VANMIERLO, et al.
- Proteostasis plays an important role in demyelinating Charcot Marie Tooth disease(2023)
Authors: Karen LIBBERECHT, Tim VANGANSEWINKEL, Ludo Van Den Bosch, Ivo LAMBRICHTS, Esther WOLFS
- LYSOSOMAL ENZYMES AND THEIR ROLE IN CHARCOT-MARIE-TOOTH DISEASE TYPE 1A(2022)
Authors: Karen LIBBERECHT, Tim VANGANSEWINKEL, Nathalie DIRKX, S. Hasevoets, Jolien VAN DEN BOSCH, Hanne JEURISSEN, Ivo LAMBRICHTS, Ludo Van den Bosch, Esther WOLFS
Pages: S169 - S170 - PMP22 OVEREXPRESSION CAUSES LIPID RECYCLING DEFECTS THAT ALTERS THE PLASMA MEMBRANE IN CMT1A(2022)
Authors: Robert Prior, Alessio Silva, Tim VANGANSEWINKEL, Arun Tharkeshwar, Iliana Michailidou, Jeroen Vreijling, Maarten Loos, Bastijn Koopmans, Nina Vlek, Nina Straat, et al.
Pages: S108